SCHEMBL6636932

SCHEMBL6636932

CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)c(Cl)c1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 4/20 0.80
ABCC3 O15438 1/20 0.72
ABCC2 Q92887 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6636924 1.00 AGTR1 (0.80) AGTR1ABCC3ABCC2
SCHEMBL9593060 0.94 AGTR1 (0.79) AGTR1ABCC3ABCC2
SCHEMBL9593073 0.94 AGTR1 (0.79) AGTR1ABCC3ABCC2
SCHEMBL6637138 0.89 AGTR1 (1.00) AGTR1ABCC3ABCC2
SCHEMBL6639612 0.89 AGTR1 (1.00) AGTR1ABCC3ABCC2
SCHEMBL6970475 0.89 AGTR1 (0.87) AGTR1ABCC3ABCC2
SCHEMBL683845 0.89 AGTR1 (0.87) AGTR1ABCC3ABCC2
SCHEMBL6963946 0.88 AGTR1 (0.82) AGTR1ABCC3ABCC2
SCHEMBL6963959 0.88 AGTR1 (0.82) AGTR1ABCC3ABCC2
SCHEMBL6957906 0.88 AGTR1 (0.78) AGTR1ABCC3ABCC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0561977-B1 USE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN THE TREATMENT OF HEMORRAGIC STROKE SMITHKLINE BEECHAM PLC (GB) 2004-05-26 EP disclosed
EP-0724387-B1 ANGIOTENSION II RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CHRONIC ANTI-INFLAMMATORY DISEASES SMITHKLINE BEECHAM CORP (US) 2003-05-02 EP disclosed
EP-0565634-B1 ANGIOTENSIN II RECEPTOR BLOCKING COMPOSITIONS SMITHKLINE BEECHAM CORP (US) 1999-03-17 EP disclosed
EP-0403159-A2 Imidazolyl-alkenoic acids SMITHKLINE BEECHAM CORPORATION (US) 1990-12-19 EP disclosed